Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine

One Bench at a Time

Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine

After completing their graduate work at Stanford, Trevor Martin and Ashley Tehranchi took 2 benches at MBC BioLabs to launch Mammoth Biosciences. Now, only seven months later, they and their colleagues have completed a $23M Series A. Mammoth Biosciences is turning UC Berkeley professor, Jennifer Doudna’s latest CRISPR discoveries into an innovative diagnostics platform. The research portion of the company will include Berkeley PhD students Janice Chen and Lucas Harrington at the helm.

MBC BioLabs and Mission Bay Capital are thrilled to have been able to help this terrific team of entrepreneurial scientists go from start to data and financing in such short order.

Upcoming Event

  • San Carlos Open House

    Come to meet MBC BioLabs residents, tour our new space in San Carlos, and hear about our exciting plans for the future. There will be posters from our companies, a live band, and an opportunity to chat with our partners and staff. RSVP In just 4 years, we have helped 116 entrepreneurial teams create fast, focused and frugal biotech companies that have gone on to raise $2.4 billion and counting. With this new facility, we can empower more entrepreneurs with the space and resources they need to tackle world changing science. Come join us in celebrating our newest MBC Biolabs campus and welcome our residents and partners!


953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287

Sign-Up for our Newsletter